Home » Topics » BioWorld Science

BioWorld Science
RSS

Syros Pharmaceuticals presents new CDK7/cyclin H inhibitors

Aug. 9, 2019

Phase II data for unadjuvanted subvirion monovalent inactivated influenza H3N2v vaccine

Aug. 9, 2019

Mapping microbial metabolites to GPCRs

Aug. 9, 2019

Risk assessment for long QT syndrome

Aug. 9, 2019

Inhibition of cystine/glutamate antiporter system Xc- identified as a possible target for epilepsy

Aug. 9, 2019

Applied Therapeutics reports data from SAD portion of phase I/II study of AT-007

Aug. 8, 2019

Novel T-cell subtype predicts risk of anaphylactic shock

Aug. 8, 2019

Chiesi Farmaceutici initiates phase I study of CHF-6523 in COPD

Aug. 8, 2019

Servier enrolling subjects in first-in-human trial of S-65487

Aug. 8, 2019

Cancer Research UK and Hummingbird Bioscience to partner to advance HMBD-001

Aug. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...